PAPER Akamatsu M, Takuma H, Yamashita T, Okada T, Keino-Masu K, Ishii K, Kwak S, Masu M, Tamaoka A
SEARCH RESULTS
330988 RESULTS
PAPER Eschbach J, Danzer KM
α-Synuclein in Parkinson's Disease: Pathogenic Function and Translation into Animal Models.
Neurodegener Dis. 2013 Sep 24; PubMed: 24080741PAPER Janezic S, Threlfell S, Dodson PD, Dowie MJ, Taylor TN, Potgieter D, Parkkinen L, Senior SL, Anwar S, Ryan B, Deltheil T, Kosillo P, Cioroch M, Wagner K, Ansorge O, Bannerman DM, Bolam JP, Magill PJ, Cragg SJ, Wade-Martins R
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):E4016-25. Epub 2013 Sep 30 PubMed: 24082145PAPER Alhebshi AH, Odawara A, Gotoh M, Suzuki I
Thymoquinone protects cultured hippocampal and human induced pluripotent stem cells-derived neurons against α-synuclein-induced synapse damage.
Neurosci Lett. 2013 Sep 27; PubMed: 24080376PAPER Hsu WL, Ma YL, Hsieh DY, Liu YC, Lee EH
STAT1 Negatively Regulates Spatial Memory Formation and Mediates the Memory-Impairing Effect of Aβ
Neuropsychopharmacology. 2013 Sep 30; PubMed: 24081304PAPER Sadak TI, Katon J, Beck C, Cochrane BB, Borson S
Key Neuropsychiatric Symptoms in Common Dementias: Prevalence and Implications for Caregivers, Clinicians, and Health Systems.
Res Gerontol Nurs. 2013 Sep 25;:1-9. PubMed: 24079749PAPER Polidori MC, Nelles G
Antioxidant Clinical Trials in Mild Cognitive Impairment and Alzheimer's Disease- Challenges and Perspectives.
Curr Pharm Des. 2013 Sep 27; PubMed: 24079767PAPER Tezil T, Basaga H
Modulation of Cell Death in Age-Related Diseases.
Curr Pharm Des. 2013 Sep 27; PubMed: 24079770PAPER Johansson L, Guo X, Hällström T, Norton MC, Waern M, Ostling S, Bengtsson C, Skoog I
Common psychosocial stressors in middle-aged women related to longstanding distress and increased risk of Alzheimer's disease: a 38-year longitudinal population study.
BMJ Open. 2013;3(9):e003142. PubMed: 24080094PAPER Wilhelmus MM, Drukarch B
Tissue transglutaminase is a biochemical marker for Alzheimer's disease.
Neurobiol Aging. 2013 Sep 27; PubMed: 24080177PAPER Bi R, Zhao L, Zhang C, Lu W, Feng JQ, Wang Y, Ni J, Zhang J, Li GD, Hu QX, Wang D, Yao YG, Li T
No association of the LRRK2 genetic variants with Alzheimer's disease in Han Chinese individuals.
Neurobiol Aging. 2014 Feb;35(2):444.e5-9. PubMed: 24080176PAPER Ye BS, Seo SW, Kim CH, Jeon S, Kim GH, Noh Y, Cho H, Yoon CW, Kim HJ, Jang EY, Lee J, Kim JH, Chin J, Lee JM, Seong JK, Choe YS, Lee KH, Na DL
Hippocampal and cortical atrophy in amyloid-negative mild cognitive impairments: comparison with amyloid-positive mild cognitive impairment.
Neurobiol Aging. 2014 Feb;35(2):291-300. PubMed: 24080178PAPER Hayden KM, Kuchibhatla M, Romero HR, Plassman BL, Burke JR, Browndyke JN, Welsh-Bohmer KA
Pre-clinical Cognitive Phenotypes for Alzheimer Disease: A Latent Profile Approach.
Am J Geriatr Psychiatry. 2013 Sep 27; PubMed: 24080384PAPER Donix M, Burggren AC, Scharf M, Marschner K, Suthana NA, Siddarth P, Krupa AK, Jones M, Martin-Harris L, Ercoli LM, Miller KJ, Werner A, von Kummer R, Sauer C, Small GW, Holthoff VA, Bookheimer SY
APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease.
Psychiatry Res. 2013 Dec 30;214(3):212-20. PubMed: 24080518PAPER Flight MH
Neurodegenerative diseases: New kinase targets for Alzheimer's disease.
Nat Rev Drug Discov. 2013 Oct;12(10):739. PubMed: 24080693Current Filters
No filters selected